Esperion Therapeutics | ESPR - EPS Earnings Per Share


Esperion Therapeutics reported $0.26 in EPS Earnings Per Share for its fiscal quarter ending in December of 2025.





Eps Change Date
AbbVie USD 2.65 0.06 Mar/2026
Alnylam Pharmaceuticals USD 1.99 0.74 Mar/2026
Alterity Therapeutics Limited AUD 0 0 Dec/2025
Amarin USD 0.14 0.06 Dec/2025
Amgen USD 5.15 0.14 Mar/2026
Biogen USD 3.57 1.58 Mar/2026
BioMarin Pharmaceutical USD 0.76 0.3 Mar/2026
Cipla INR 6.86 8.34 Mar/2026
CSL USD 5.07 3 Dec/2025
Cytokinetics USD -1.67 0.17 Mar/2026
Daiichi Sankyo JPY 48.75 1.96 Mar/2026
Eli Lilly USD 8.55 1.01 Mar/2026
Esperion Therapeutics USD 0.26 0.42 Dec/2025
Geron USD -0.01 0.04 Mar/2026
Grifols EUR 0.16 0.02 Mar/2026
Halozyme Therapeutics USD 1.6 1.84 Mar/2026
Heron Therapeutics USD -0.02 0.02 Dec/2025
Ionis Pharmaceuticals USD -0.56 0.85 Mar/2026
Merck USD -1.28 3.32 Mar/2026
Minerva Neurosciences USD -0.56 3.53 Dec/2024
Moderna USD -3.4 1.29 Mar/2026
Nektar Therapeutics USD -1.35 1.17 Dec/2025
Pfizer USD 0.75 0.09 Mar/2026
PTC Therapeutics USD -0.03 1.64 Mar/2026
Puma Biotechnology USD 0.41 0.5 Sep/2024
Regeneron Pharmaceuticals USD 9.47 1.97 Mar/2026
Sanofi EUR 1.88 0.35 Mar/2026
Sarepta Therapeutics USD 3.16 6.74 Mar/2026
United Therapeutics USD 5.82 1.88 Mar/2026
Vanda Pharmaceuticals USD -0.09 0 Dec/2024